Deciphering Neuroinflammatory Pathways in Trigeminal Neuralgia: Insights from the CGRP/SP-Piezo2-Ca2+ Axis

Study Background and Research Question

Trigeminal neuralgia (TN) is a debilitating neuropathic pain disorder characterized by intense, paroxysmal orofacial pain, often triggered by innocuous mechanical stimuli. While microvascular compression at the trigeminal root entry zone (TREZ) is a common etiology, the precise molecular mechanisms linking nerve root insult to persistent pain remain incompletely understood. Recent research has increasingly implicated neuroinflammation and aberrant mechanotransduction in the pathophysiology of TN. However, the interplay between neuroinflammatory mediators, mechanosensitive ion channels, and intracellular signaling pathways, and how these contribute to the persistent mechanical allodynia characteristic of TN, has not been fully elucidated. The study by Liao et al. directly addresses these knowledge gaps by dissecting the signaling events that couple chronic trigeminal nerve compression to sustained pain hypersensitivity via the CGRP/SP-Piezo2-Ca2+ axis (Liao et al., Cellular & Molecular Biology Letters, 2026).

Key Innovation from the Reference Study

The central innovation of the Liao et al. study lies in establishing a mechanistic link between ATP-driven intracellular Ca2+ signaling, neuropeptide release (CGRP and substance P), and the upregulation of the mechanosensitive channel Piezo2 in the context of nerve injury-induced neuroinflammation. Specifically, the authors delineate a positive feedback loop wherein neuroinflammatory responses in the trigeminal ganglion (TG) and peripheral tissue (whisker pad) amplify Piezo2 expression and activity, thereby exacerbating mechanical allodynia. The study is among the first to demonstrate that Piezo2, together with its associated neuropeptide receptors and downstream Ca2+-dependent kinases, acts as a critical node mediating peripheral sensitization in TN. Notably, the authors also show that inhibiting cAMP signaling in the whisker pad can alleviate pain hypersensitivity, and that Piezo2 knockdown reverses cAMP analog-induced allodynia, highlighting potential intervention points for future research.

Methods and Experimental Design Insights

Liao et al. utilized a multifaceted in vivo and in vitro approach to interrogate the pathogenesis of TN. Key elements of the experimental design include:

• Establishment of a chronic constriction injury model targeting the TREZ in rats to replicate the clinical features of TN, notably mechanical allodynia.
• Behavioral assessments of mechanical sensitivity (allodynia) in affected animals, providing a functional readout for pain states.
• Immunohistochemical and molecular analyses to evaluate the expression and spatial distribution of Piezo2, CGRP, SP, and their respective receptors in the TG and peripheral tissues.
• Pharmacological manipulation of signaling pathways, including targeted inhibition of cAMP signaling in vivo using local administration to the whisker pad.
• In vitro stimulation of primary cell cultures with extracellular ATP to model neuroinflammatory activation and dissect downstream Ca2+-dependent signaling cascades (involving ERK1/2 and p38 MAPK).
• Genetic knockdown experiments targeting Piezo2 in both TG and whisker pads to assess the requirement of this channel in mediating cAMP-induced hyperalgesia.

This comprehensive methodological framework enabled the authors to causally link molecular signaling events with behavioral outputs, strengthening the study's translational relevance.

Core Findings and Why They Matter

The study demonstrates several critical findings:

• Neuroinflammatory Response Initiation: Chronic TREZ compression triggers robust neuroinflammation in the TG and peripheral tissue, as evidenced by elevated expression of proinflammatory cytokines and neuropeptides.
• Piezo2 as a Central Node: Piezo2, a mechanosensitive ion channel, is co-expressed with CGRP and SP receptor complexes on Merkel cells. Its upregulation correlates with increased mechanical allodynia in TN models. This highlights Piezo2 as a convergence point for neuroinflammatory and mechanotransductive signals.
• Ca2+-Dependent Kinase Activation: Both in vivo and in vitro, ATP-induced Ca2+ influx activates downstream kinases (ERK1/2, p38 MAPK) and transcription factors, driving the expression of Piezo2 and neuropeptides. This axis constitutes a positive feedback loop maintaining peripheral sensitization.
• Role of cAMP Signaling: Local inhibition of cAMP signaling in the whisker pad alleviated mechanical allodynia, while exogenous cAMP analog administration exacerbated pain, contingent upon Piezo2 expression. These results suggest that cAMP signaling is a permissive factor for Piezo2-mediated sensitization in the neuroinflammatory microenvironment.

Together, these findings clarify how neuroinflammatory responses after nerve injury can directly modulate mechanotransduction machinery, sustaining chronic pain states in TN. The delineation of the Ca2+-CGRP/SP-Piezo2 axis provides a mechanistic roadmap for exploring targeted interventions that disrupt this cycle.

Comparison with Existing Internal Articles

Several recent articles have advanced the use of cAMP analogs, such as Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt), for interrogating the cAMP signaling pathway in diverse experimental contexts. For example, one internal review discusses the value of DBcAMP sodium salt as a tool for dissecting cAMP-dependent protein kinase activation and its translational potential in neurodegenerative and inflammatory disease modeling. Another benchmarking resource highlights the reagent's applicability across neurobiological and inflammation modulation studies, citing its robust cell permeability and signal transduction reliability. However, these resources primarily focus on endothelial injury, hemostasis, and synaptic mechanisms, with less emphasis on the mechanotransductive-neuroinflammatory interface central to TN.

The Liao et al. study extends these applications by directly linking cAMP signaling manipulation (including the use of stable cAMP analogs) to the modulation of Piezo2-dependent pain sensitization in a well-defined neuroinflammatory model. This positions DBcAMP sodium salt not just as a generic cAMP analog for research, but as a strategic reagent for probing the intersection of cAMP, Ca2+ signaling, and mechanosensory pathways in neuropathic pain.

Limitations and Transferability

Despite its strengths, the study presents several limitations:

• Species and Model Constraints: The primary findings are derived from rat models of TN, which, while recapitulating many clinical features, may not fully capture the human disease complexity.
• Cellular Heterogeneity: While the focus on the TG neuron–Merkel cell axis is justified, the broader cellular landscape of neuroinflammation (including glial and immune contributors) warrants further investigation.
• Pharmacological Specificity: The systemic effects of cAMP analogs and other inhibitors used in vivo may have off-target consequences that complicate interpretation.
• Temporal Dynamics: The chronicity and reversibility of the identified feedback loop, especially in the context of established pain states, remain to be clarified in longer-term studies.

Nevertheless, the molecular framework proposed by Liao et al. is likely to be transferable to other forms of peripheral neuropathic pain where mechanosensitive ion channels and neuroinflammation co-exist.

Protocol Parameters

• Animal model induction: Chronic constriction injury applied to the trigeminal root entry zone (TREZ) to induce TN-like allodynia in rats.
• Behavioral assessment: Von Frey filaments used to evaluate mechanical allodynia post-injury.
• In vivo cAMP pathway manipulation: Localized administration of cAMP analogs or inhibitors (e.g., DBcAMP sodium salt) to the whisker pad, with timing and concentration optimized for acute versus chronic sensitization studies.
• Piezo2 knockdown: Genetic or pharmacological strategies targeting both TG and peripheral tissues to dissect channel-specific contributions.
• In vitro pathway stimulation: Application of extracellular ATP and Ca2+ modulators to primary sensory neuron or Merkel cell cultures to recapitulate neuroinflammatory signaling.

Research Support Resources

For investigators seeking to replicate or expand on these workflows, Dibutyryl-cAMP, sodium salt (SKU B9001) from APExBIO provides a stable, cell-permeable cAMP analog suitable for selective activation of cAMP-dependent pathways in both in vivo and in vitro settings. Its solubility and stability characteristics facilitate use in protein kinase A activation assays, inflammation modulation studies, and mechanotransduction research as outlined above. While the reference study underscores the pivotal role of cAMP signaling in TN pathogenesis, researchers should tailor analog use and dosing to their specific experimental models and consult primary literature for context-specific optimization.